Advertisement

Adaptation of the Organism during Long-Lasting Survival with a Total Artificial Heart

  • J[aromír] Vašků
  • P. Hanzelka
  • J. Černý
  • J[an] Vašků
  • E. Urbánek
  • M. Dostál
  • P. Guba
  • V. Pavlíček
  • Z. Gregor
  • V. Krčma
  • H. Janečková
  • O. Šotolová
  • T. Sládek
  • B. Hartmannová
  • E. Šotáková
  • P. Wendsche
  • L. Krček
  • P. Urbánek
  • M. Gregorová

Abstract

The present chapter is a report of the current status of our testing of total artificial heart (TAH) implants in over 50 calves. Our 50th TAH experiment was performed with the calf Hasan; the experiment lasted 150 days. The TAH used in this experiment was TNS-BRNO-II, made of polymethylmethacrylate with polyurethane diaphragm and valves. Basic physiological functions normalized very soon after surgery. Blood flow through the device gradually increased from 7.5 to 11.5–12.5 liter/min at the end of the experiment. Central venous pressure (CVP) increased to 2.0–2.5 kPa in later months; atrial pressures were automatically maintained at the same level, ca. 1 kPa on both sides during the whole experiment. Anticoagulant therapy kept the prothrombin time two- to threefold above normal. The experiment was terminated by a sudden impairment of the blood coagulation mechanism, marked GI bleeding, and acute cerebral anemic anoxia. Autopsy revealed no thrombi at the artificial valves; there was thick pseudo-neointima in the outer portion of the diaphragm; inlet orifices were clean, without traces of pannus on either side. There were no signs of infection of organs detectable by the autopsy, but bacteriological examination revealed Klebsiella infection. Another experiment with the TAH, no. 51, was started immediately after experiment no. 50 was terminated. The calf, named Dalibor, recovered very quickly from surgery and anesthesia; about 3 weeks after surgery, basic physiological functions were stabilized , and during the subsequent course there were no problems in postoperative care. The calf was anticoagulated with warfarin (Coumadin®) until the 102nd day when slight GI bleeding occurred, and the administration of warfarin was interrupted. Only antiaggregation therapy with dipyridamole (Curantyl®) and aspirin was used from that time. Dalibor survived for 142 days in full health and died of accidental causes. During the calf s survival period, its CVP oscillated between 3 and 2.8 kPa, and blood flow through the TAH averaged 13 liter/min. The technical equipment used in both these experiments functioned without the slightest disturbance. In both experiments, the internal milieu of the calves showed absolute adaptation and normalization of all basic parameters, especially in the second calf, Dalibor. A third calf, no. 52, Samson, of this group survived 104 days; the cause of death was diaphragm leakage in the right-hand pump. The longest survival to date was achieved in calf no. 53, Florian, which survived 155 days; the cause of death was microthrombembolization in the CNS. The last calf of this group, no. 54, Waldemar, survived 31 days; the experiment was terminated because of a thrombembolism into the superior mesenteric artery. The mean survival of our five calves that lived longer than 1 month was 116 days. During their survival time, the basic physiological functions of all of these animals were fully normalized; the calves gained weight, and their condition was very good. These facts have documented excellent adaptation of these animals to the TAH. The control and driving unit used in our experiments with the TAH is an apparatus produced in our institute and designated Chirasist TN 3.

Keywords

Central Venous Pressure Artificial Heart Left Atrial Pressure Total Artificial Heart Internal Milieu 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fukumasu, H., Iwaya, F., Olsen, D. B., Lawson, J. H., and Kolff, W. J. 1979. Surgical implantation of the Jarvik-5 total artificial heart in a calf. Trans. Am. Soc. Artif. Intern. Organs 25:232–238.PubMedCrossRefGoogle Scholar
  2. 2.
    Hanzelka, P., Krčma, V., Svoboda, P., Trbušek, V., Urbánek, P., Vašků, J[an], Vašků, J[aromír], Urbánek, E., and Dostál, M. 1980, BRNO-I, an implantable diaphragm-type artificial heart: Technical aspects of design. Artif. Organs 4:65–67.PubMedCrossRefGoogle Scholar
  3. 3.
    Hanzelka, P., Vašků, J[an], Urbánek, P., Vašků, J[aromír], and Urbânek, E. 1979. Determination of cardiac output of the artificial heart from the drive air flow. Artif. Organs 3:277–278.PubMedCrossRefGoogle Scholar
  4. 4.
    Hennig, E., Grosse-Siestrup, C., Krautzberger, W., Kless, H., and Bücheri, E. S. 1978. The relationship of cardiac output and venous pressure in long surviving calves with total artificial heart. Trans. Am. Soc. Artif. Intern. Organs, 24:616–623.PubMedGoogle Scholar
  5. 5.
    Lawson, J. H., Fukumasu, H., Olsen, D. B., Jarvik, R. K., Kessler, T. R., Coleman, D., Pons, A. B., Blaylock, R., and Kolff, W. J. 1979. Six month survival of a calf with an artificial heart. J. Thorac. Cadiovasc. Surg. 78:150–156.Google Scholar
  6. 6.
    Lawson, J., Olsen, D. B., Kolff, W. J., Liu, W. S., Hershgold, E. J., and van Kampen, K. 1976. A three month survival of a calf with an artificial heart. J. Lab. Clin. Med. 87:848–858.PubMedGoogle Scholar
  7. 7.
    Olsen, D. B., and Kolff, W. J. 1982. The total artificial heart. In: D. Liotta, and C. Cabrol (eds.), Cardiac Surgery Today, Maloine Editeur, Paris (in preparation).Google Scholar
  8. 8.
    Shaffer, L. J., Donachy, J. H., Rosenberg, G., Phillips, W. M., Landis, D. L., Prophet, G. A., Olsen, E., Arrowood, J. A., and Pierce, W. S. 1979. Total artificial heart implantation in calves with pump of an angled port design. Trans. Am. Soc. Artif. Intern. Organs 25:254–259.PubMedCrossRefGoogle Scholar
  9. 9.
    Tsushima, N., Kasai, S., Koshino, I., Jacobs, G., Morinaga, N., Washizu, T., Kiraly, R., and Nosé, Y. 1977. 145 days survival of calf with total artificial heart (TAH). Trans. Am. Soc. Artif. Intern. Organs 23:526–534.PubMedCrossRefGoogle Scholar
  10. 10.
    Vašků, J[aromír]. 1980. [Pathophysiological aspects of the present research state of the mechanical assisted circulation and of the total heart replacement.] Bratisl. Lek. Listy 73:649–661.PubMedGoogle Scholar
  11. 11.
    Vašků, J[aromír], Černy, J., Hanzelka, P., Dostál, M., Guba, P., Urbánek, E., Sládek, T., Urbánek, P., Šotolová, O., Kréek, L., Vašků, J[an]. 1978. First experience with short and long term survival with the Czechoslovak TAH—TNS-BRNO-I. ESAO Proc. 5:99–103.Google Scholar
  12. 12.
    Vašků, J[aromír], Černý, J., Hanzelka, P., Vašků, J[an], Urbánek, E., Dostál, M., Urbánek, P., Guba, P., Pavlíček, V., Krček, L., Sládek, T., Hartmannová, B., Filkuka, J., Janečková, H., Šotolová, O., Šotáková, E., Doležel, S., Krčma, V., Cídl, K., and Bednařík, B. 1981. 150-Day survival of a calf with a polymethylmethacrylate total artificial heart: TNS-BRNO-II. Artif. Organs 5:388–400.PubMedCrossRefGoogle Scholar
  13. 13.
    Vašků, J[aromír], Doležel, S., Černý, J., Dostál, M., Urbánek, E., Hanzelka, P., Vašků, J[an], Guba, P., Hartmannová, B., and Sládek, T. 1979. Changes in the monoaminergic innervation of the biological atrial remnants after implantation of TAH (Total Artificial Heart). ESAO Proc. 6:9–13.Google Scholar
  14. 14.
    Vašků, J., Urbánek, E., Černý, J., Urbánek, P., Dostál, M., Hanzelka, P., Dařena, F., and Sládek, T. 1977. Our first experiences with the total heart replacement by artificial heart. ESAO Proc. 4:380–408.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • J[aromír] Vašků
    • 1
    • 2
  • P. Hanzelka
    • 1
    • 2
  • J. Černý
    • 1
    • 2
  • J[an] Vašků
    • 1
    • 2
  • E. Urbánek
    • 1
    • 2
  • M. Dostál
    • 1
    • 2
  • P. Guba
    • 1
    • 2
  • V. Pavlíček
    • 1
    • 2
  • Z. Gregor
    • 1
    • 2
  • V. Krčma
    • 1
    • 2
  • H. Janečková
    • 1
    • 2
  • O. Šotolová
    • 1
    • 2
  • T. Sládek
    • 1
    • 2
  • B. Hartmannová
    • 1
    • 2
  • E. Šotáková
    • 1
    • 2
  • P. Wendsche
    • 1
    • 2
  • L. Krček
    • 1
    • 2
  • P. Urbánek
    • 1
    • 2
  • M. Gregorová
    • 1
    • 2
  1. 1.Institute of Pathological Physiology, Faculty of Medicine, IInd Surgical ClinicUniversity of J. E. PurkinjeCzechoslovakia
  2. 2.Research Center for Heart Support and Total Heart SubstitutionRegional Institute of National HealthBrnoCzechoslovakia

Personalised recommendations